首页 | 本学科首页   官方微博 | 高级检索  
     

HE4联合 CA125检测对卵巢良恶性肿瘤的诊断价值
引用本文:程喜锋,权晓芳,安瑞芳. HE4联合 CA125检测对卵巢良恶性肿瘤的诊断价值[J]. 中国妇幼健康研究, 2014, 0(2): 273-275
作者姓名:程喜锋  权晓芳  安瑞芳
作者单位:程喜锋 (西安交通大学医学院第一附属医院妇产科,陕西西安 710061 陕西中医学院第二附属医院,陕西咸阳 712000); 权晓芳 (中国兵器工业五二一医院,陕西西安,710061); 安瑞芳 (西安交通大学医学院第一附属医院妇产科,陕西西安,710061);
摘    要:
目的:探讨人附睾上皮分泌蛋白4(HE4)对卵巢癌的诊断意义及其与糖链抗原CA125联合检测对卵巢良、恶性肿瘤的诊断价值。方法检测22例卵巢癌患者、46例卵巢良性肿瘤患者及35例健康女性血清中的HE4和CA125水平。 CA125的测定采用适用于96微孔反应板的时间分辨荧光测定仪测量,通过双抗体夹心时间分辨免疫荧光分析法进行测定。 HE4的测定应用电化学发光法进行测定。结果卵巢癌组HE4水平明显高于卵巢良性肿瘤和健康对照组,差异均具有统计学意义(t1=3.356, t2=3.865,均P<0.05);卵巢癌组血清CA125水平也高于卵巢良性肿瘤组和健康对照组,差异均有统计学意义( t1=4.656,t2=5.126,均P<0.05)。单独检测HE4的灵敏度和特异度分别为77.27%和84.78%;单独检测CA125的灵敏度和特异度分别为90.91%和80.43%;二者联合检测时灵敏度和特异度分别为72.73%和89.13%。结论 HE4对卵巢癌的诊断有较高的特异度;CA125的特异度低于HE4;HE4对卵巢癌的诊断价值优于单独CA125检测;联合检测提高了特异度,降低了的灵敏度。

关 键 词:卵巢肿瘤  人附睾上皮分泌蛋白4  糖链抗原CA125  灵敏度  特异度

Values of human epididymis protein 4 combined with carbohydrate antigen 125 in diagnosis of human ovarian cancer and ovarian benign tumors
CHENG Xi-feng,QUAN Xiao-fang,AN Rui-fang. Values of human epididymis protein 4 combined with carbohydrate antigen 125 in diagnosis of human ovarian cancer and ovarian benign tumors[J]. Chinese Journal of Maternal and Child Health Research, 2014, 0(2): 273-275
Authors:CHENG Xi-feng  QUAN Xiao-fang  AN Rui-fang
Affiliation:1. Department of Gynecology and Obstetrics, The First Affiliated Hospital of Xi' an Jiaotong University, Shaanxi Xi' an 710061, China 2. The Second Affiliated Hospital of Shaanxi University of Chinese Medicine, Shaanxi Xianyang 712000, China ; 3. Five Two One Hospital of Chinese Weapon Industry, Shaanxi Xi' an 710061, China)
Abstract:
Objective To explore the diagnostic value of human epididymis protein 4 (HE4) in ovarian cancer and that of HE4 combined with carbohydrate antigen 125 ( CA125) in human ovarian cancer and ovarian benign tumors .Methods Serum levels of HE4 and CA125 in 22 cases of ovarian cancer , 46 cases of ovarian benign tumors and 35 cases of healthy controls were detected .Time-resolved fluorescence measurement apparatus applicable to 96 microporous reaction plate was used , and CA125 was measured by double antibody sandwich time-resolved immunofluorescence analysis method .Electrochemical luminescence method was used to determine HE 4.Results Serum levels of HE4 among ovarian cancer patients were obviously higher than those of ovarian benign tumors and healthy controls , and the difference was statistically significant (t1 =3.356,t2 =3.865, both P〈0.05).Serum levels of CA125 among ovarian cancer patients were obviously higher than those of ovarian benign tumors and healthy controls , and there was significant difference ( t1 =4.656,t2 =5.126, both P〈0.05).The sensitivity and specificity of HE4 was 77.27%and 84.78%, respectively, while the sensitivity and specificity of CA125 was 90.91%and 80.43%, respectively.The sensitivity and specificity of joint detection was 72.73%and 89.13%, respectively.Conclusion HE4 has high specificity in detecting ovarian cancer , which is higher than CA125.The diagnostic value of HE4 is superior to CA125 in detecting ovarian cancer .Joint detection improves specificity but reduces sensitivity .
Keywords:ovarian tumor  sensitivity  specificity
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号